MENLO PARK, Calif. and SINGAPORE, Might 18, 2022 (Globe NEWSWIRE) — ASLAN Prescription drugs (NASDAQ: ASLN), a clinical-phase, immunology-centered biopharmaceutical organization building progressive remedies to completely transform the life of sufferers, these days declared that Dr Carl Firth, CEO, will present a corporation update at the H.C. Wainwright Worldwide Expense Meeting. The meeting will be held practically and in-human being from May well 23 to 26, 2022.
ASLAN management will also be offered for virtual just one-on-a single meetings all over the conference. Remember to contact your agent at H.C. Wainwright to ask for a meeting.
About ASLAN Prescription drugs
ASLAN Pharmaceuticals (Nasdaq: ASLN) is a clinical-phase, immunology-concentrated biopharmaceutical business producing modern therapies to remodel the life of sufferers. ASLAN is currently analyzing eblasakimab, a prospective 1st-in-course antibody targeting the IL-13 receptor, in atopic dermatitis, and farudodstat (also recognised as ASLAN003), a potent oral inhibitor of the enzyme, DHODH, in autoimmune condition. ASLAN has a crew in Menlo Park, California, and in Singapore. For supplemental facts be sure to stop by www.aslanpharma.com or comply with ASLAN on LinkedIn.
Media and IR contacts